These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29468960)

  • 41. PDF inhibitors: an emerging class of antibacterial drugs.
    Johnson KW; Lofland D; Moser HE
    Curr Drug Targets Infect Disord; 2005 Mar; 5(1):39-52. PubMed ID: 15777197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-Based Drug Design of Small Molecule Peptide Deformylase Inhibitors to Treat Cancer.
    Gao J; Wang T; Qiu S; Zhu Y; Liang L; Zheng Y
    Molecules; 2016 Mar; 21(4):396. PubMed ID: 27023495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial spectrum and activity of NVP PDF-713, a novel peptide deformylase inhibitor, tested against 1,837 recent Gram-positive clinical isolates.
    Jones RN; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2004 May; 49(1):63-5. PubMed ID: 15135503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression, purification, and activity assay of peptide deformylase from Escherichia coli and Staphylococcus aureus.
    Che X; Hu J; Wang L; Zhu Z; Xu Q; Lv J; Fu Z; Sun Y; Sun J; Lin G; Lu R; Yao Z
    Mol Cell Biochem; 2011 Nov; 357(1-2):47-54. PubMed ID: 21603885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibacterial Effect of 2R,3R-dihydromyricetin on the Cellular Functions of Staphylococcus aureus.
    Wu YP; Bai JR; Zhong K; Bai DD; Huang YN; Xiao K; Ran Y; Gao H
    Biosci Biotechnol Biochem; 2018 Jan; 82(1):135-138. PubMed ID: 29235425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.
    Hu X; Nguyen KT; Jiang VC; Lofland D; Moser HE; Pei D
    J Med Chem; 2004 Sep; 47(20):4941-9. PubMed ID: 15369398
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties.
    Joshi SD; Dixit SR; Kirankumar MN; Aminabhavi TM; Raju KV; Narayan R; Lherbet C; Yang KS
    Eur J Med Chem; 2016 Jan; 107():133-52. PubMed ID: 26580979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proteomic study of peptide deformylase inhibition in Streptococcus pneumoniae and Staphylococcus aureus.
    Wang W; White R; Yuan Z
    Antimicrob Agents Chemother; 2006 May; 50(5):1656-63. PubMed ID: 16641432
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crystal structure of peptide deformylase from Staphylococcus aureus in complex with actinonin, a naturally occurring antibacterial agent.
    Yoon HJ; Kim HL; Lee SK; Kim HW; Kim HW; Lee JY; Mikami B; Suh SW
    Proteins; 2004 Nov; 57(3):639-42. PubMed ID: 15382235
    [No Abstract]   [Full Text] [Related]  

  • 50. Characterization of peptide deformylase homologues from Staphylococcus epidermidis.
    Lin P; Hu T; Hu J; Yu W; Han C; Zhang J; Qin G; Yu K; Götz F; Shen X; Jiang H; Qu D
    Microbiology (Reading); 2010 Oct; 156(Pt 10):3194-3202. PubMed ID: 20656778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peptide deformylase inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and biological results.
    Pichota A; Duraiswamy J; Yin Z; Keller TH; Alam J; Liung S; Lee G; Ding M; Wang G; Chan WL; Schreiber M; Ma I; Beer D; Ngew X; Mukherjee K; Nanjundappa M; Teo JW; Thayalan P; Yap A; Dick T; Meng W; Xu M; Koehn J; Pan SH; Clark K; Xie X; Shoen C; Cynamon M
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6568-72. PubMed ID: 19008098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and in vitro antibacterial activity of oxazolidine LBM-415 analogs as peptide deformylase inhibitors.
    Yu L; Zhou W; Wang Z
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1541-4. PubMed ID: 21288715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of a human peptide deformylase: implications for antibacterial drug design.
    Nguyen KT; Hu X; Colton C; Chakrabarti R; Zhu MX; Pei D
    Biochemistry; 2003 Aug; 42(33):9952-8. PubMed ID: 12924944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fumimycin: a peptide deformylase inhibitor with an unusual skeleton produced by Aspergillus fumisynnematus.
    Kwon YJ; Sohn MJ; Zheng CJ; Kim WG
    Org Lett; 2007 Jun; 9(13):2449-51. PubMed ID: 17523650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, synthesis, antibacterial activity and docking study of some new trimethoprim derivatives.
    Rashid U; Ahmad W; Hassan SF; Qureshi NA; Niaz B; Muhammad B; Imdad S; Sajid M
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5749-5753. PubMed ID: 28327306
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Formyl peptide receptor-mediated proinflammatory consequences of peptide deformylase inhibition in Staphylococcus aureus.
    Mader D; Rabiet MJ; Boulay F; Peschel A
    Microbes Infect; 2010 May; 12(5):415-9. PubMed ID: 20156579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel class of inhibitors of peptide deformylase discovered through high-throughput screening and virtual ligand screening.
    Howard MH; Cenizal T; Gutteridge S; Hanna WS; Tao Y; Totrov M; Wittenbach VA; Zheng YJ
    J Med Chem; 2004 Dec; 47(27):6669-72. PubMed ID: 15615515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid identification of antibacterial agents effective against Staphylococcus aureus using small-molecule macroarrays.
    Bowman MD; O'Neill JC; Stringer JR; Blackwell HE
    Chem Biol; 2007 Apr; 14(4):351-7. PubMed ID: 17462570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolates.
    Jones RN; Moet GJ; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2004 May; 53(5):804-7. PubMed ID: 15056649
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, synthesis, and antibacterial activity of 2,5-dihydropyrrole formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
    Shi W; Duan Y; Qian Y; Li M; Yang L; Hu W
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3592-5. PubMed ID: 20510610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.